Dear Colleague,

There’s no other event for networking and learning with biotech executives like the FierceBiotech Drug Development Forum. Now in its third year, this event features an all-new agenda built directly from your feedback. Join us on October 1–3 in Boston for exclusive insights on how to improve your partnership and pipeline strategies, streamline funding and development, and guide early research towards success.

Do you need to focus on STRATEGIC DEAL-MAKING AND PARTNERING?

• Update Collaboration Models Between Pharma and Biotech
• Recognize When Novel Technologies Can Disrupt Standard Business Development
• Manage Partnerships and Portfolios to Survive the Next Market Downturn
• Uncover Warning Signs of Failing Partnerships
• Move Into Specialty Arena to Achieve Higher Value Assets

...and more!

Or, are your greatest worries about BREAKTHROUGHS IN EARLY STAGE RESEARCH?

• Set Orphan Drug Strategy so Your Company Can Grow up With Your Patients
• Determine “Best-in-Breed” Status in Immuno-Oncology
• Find New Drivers for Success After Prior Failures in CNS, Oncology, Rare Disease, and Gene Therapy
• Judge the Usefulness of Dedicated Innovation Groups
• Advance CRISPR Innovation in First-in-Human Trials

...and more!

Join 90+ executive speakers, including:

…and many more!

The agenda is nearly completed — if you’d like to be among the first notified when it is ready, CLICK HERE.

Our Early Bird registration rate saves you $200 off the standard price! To take advantage of the best savings on this event and save your seat today, click here.

I look forward to seeing you in Boston this fall!

Sincerely,

Matt Greenbaum
Production Team Leader
ExL Events

For sponsorship and exhibition opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com.